A23K50/50

NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS
20210290663 · 2021-09-23 ·

Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of said composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.

Use of substituted benzylideneguanidine derivatives as synergists for polymyxin antibiotics

A use of a substituted benzoguanidine derivative as a polymyxin antibiotic synergist, particularly as a synergist and a drug resistance reversal agent of the polymyxin antibiotic for inhibiting a sensitive strain, or a composition comprising the same in combination with a polymyxin antibiotic for preparing a compound pharmaceutical preparation for human or animal use in the treatment of a disease caused by a gram-negative bacterial infection or the preparation a growth-promoting feed additive and for the raising of livestock animals.

BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS
20210244696 · 2021-08-12 ·

Compositions and methods are related to utilizing glycine and N-acetylcysteine for a variety of medical conditions related to reduced levels of glycine, N-acetylcysteine, and/or glutathione, for example, muscle loss such as sarcopenia, HIV infection and other infections, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and other conditions.

BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS
20210244696 · 2021-08-12 ·

Compositions and methods are related to utilizing glycine and N-acetylcysteine for a variety of medical conditions related to reduced levels of glycine, N-acetylcysteine, and/or glutathione, for example, muscle loss such as sarcopenia, HIV infection and other infections, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and other conditions.

ANTLER SAVER RODENT CHEWS
20210219572 · 2021-07-22 ·

A method for preventing rodents from damaging shed antlers is disclosed. The method includes the steps of: creating a mineral block constructed to be placed in a wintering grounds of antlered deer prior to antler cast-off, the mineral block containing at least phosphorus and calcium salts; mixing at least a powdered phosphorus salt and a powdered calcium salt to create a salt mixture; combining the salt mixture with a powdered mortar; adding water to the salt mixture and powdered mortar to produce a wet mortar; placing the wet mortar in a mold and allowing it to dry to form the mineral block; and, removing the mold from formed mineral block. The resulting product may then be distributed as necessary in a specified area where antler cast-offs are present.

ANTLER SAVER RODENT CHEWS
20210219572 · 2021-07-22 ·

A method for preventing rodents from damaging shed antlers is disclosed. The method includes the steps of: creating a mineral block constructed to be placed in a wintering grounds of antlered deer prior to antler cast-off, the mineral block containing at least phosphorus and calcium salts; mixing at least a powdered phosphorus salt and a powdered calcium salt to create a salt mixture; combining the salt mixture with a powdered mortar; adding water to the salt mixture and powdered mortar to produce a wet mortar; placing the wet mortar in a mold and allowing it to dry to form the mineral block; and, removing the mold from formed mineral block. The resulting product may then be distributed as necessary in a specified area where antler cast-offs are present.

Bacteria and enzymes produced therefrom and methods of using same

A bacteria referred to here as Bacillus subtilis 6A-1 is provided, compositions thereof and processes for use of the bacteria, spores, cells, extracts and enzymes. The compositions which comprise the bacteria, spores, cells, extracts and/or enzymes are capable of degrading polysaccharides. Such compositions are capable of degrading cellulose, including plant-produced cellulose, microcrystalline cellulose and carboxymethyl cellulose. The bacteria produces at least two cellulose-degrading protein fractions. Cellulose degrading activity continues across pH2 to pH13.

Bacteria and enzymes produced therefrom and methods of using same

A bacteria referred to here as Bacillus subtilis 6A-1 is provided, compositions thereof and processes for use of the bacteria, spores, cells, extracts and enzymes. The compositions which comprise the bacteria, spores, cells, extracts and/or enzymes are capable of degrading polysaccharides. Such compositions are capable of degrading cellulose, including plant-produced cellulose, microcrystalline cellulose and carboxymethyl cellulose. The bacteria produces at least two cellulose-degrading protein fractions. Cellulose degrading activity continues across pH2 to pH13.

COMPOSITION FOR PREVENTING, IMPROVING, OR TREATING AUTISM SPECTRUM DISORDERS INCLUDING AGATHOBACULUM SP. STRAIN AS ACTIVE INGREDIENT

The present invention relates to an Agathobaculum sp. strain having prophylactic or therapeutic effects on autism spectrum disorders, and use thereof. When the intestinal microorganism Agathobaculum sp. strain of the present invention was orally administered to valproic acid (VPA)-induced autism model mice and BTBR autism model mice, the effects of remarkably improving autism spectrum disorders including repetitive behaviors, hyperactivity, social deficiency and cognitive/memory dysfunction of the mice were observed, as compared with a non-treated control. Accordingly, it may be usefully applied to foods, drugs, or feeds for preventing or treating autism spectrum disorders, and thus is very useful in the relevant industries.

Novel Lactobacillus Fermentum LM1016 Strain, And Composition For Preventing Or Treating Cardiovascular Diseases
20210115392 · 2021-04-22 · ·

The present invention relates to a novel strain of Lactobacillus fermentum LM1016 deposited with the Korean Culture Center of Microorganisms under accession number KCCM12468P. The novel strain of the present invention has an effect of treating or preventing cardiovascular diseases, obesity, fatty liver or diabetes mellitus.

The present invention relates to a composition comprising the strain, and the composition may be used in a pharmaceutical product, a health functional food, a dairy product, a fermented product, a food additive and an animal feed and the like.